Complement – 4 (C4)

The Complement 4 (C4) test measures the level of C4 protein in the blood, which is a crucial component of the complement system—a part of the immune system responsible for fighting infections and clearing immune complexes. Abnormal C4 levels may indicate autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis, or vasculitis, as well as recurrent infections or liver disease. Low C4 can suggest complement consumption due to immune activation, while high levels may reflect inflammation. The test helps clinicians assess immune function, monitor disease activity, and guide treatment decisions.Reports On : With 12 HoursSample Type : BloodFasting : Not Required Click Here To Book A Test

0 Comments

Complement – 3 (C3)

The Complement-3 (C3) test measures the level of complement component 3, a key protein in the immune system that plays a central role in inflammation and defense against infections. C3 is part of the complement system, which helps antibodies and phagocytic cells clear pathogens and damaged cells. Abnormal C3 levels can indicate immune deficiencies, autoimmune disorders, or ongoing infections. Low levels are often seen in conditions like systemic lupus erythematosus (SLE) or post-infectious glomerulonephritis, while elevated levels may occur during acute inflammation. Monitoring C3 helps assess disease activity and guide treatment.Reports On : With 12 HoursSample Type : BloodFasting : Not Required Click Here To Book A Test

0 Comments

CMV IgM

The CMV IgM test detects immunoglobulin M antibodies specific to cytomegalovirus (CMV) in the blood, indicating a recent or current CMV infection. CMV is a common virus belonging to the herpesvirus family, often asymptomatic in healthy individuals but potentially serious in pregnant women and immunocompromised patients. A positive CMV IgM result suggests recent exposure or active infection, while a negative result typically indicates no recent infection. This test helps in diagnosing primary CMV infection, guiding clinical management, and assessing risks in pregnancy or immunocompromised states.Reports On : With 24 HoursSample Type : BloodFasting : Not Required Click Here To Book A Test

0 Comments